Introduction: A polymorphism in the angiotensin-converting enzyme gene (ACE I/D
polymorphism) has been associated with increased risk for cardiovascular disease (CVD) …

BACKGROUND The participation of the renin-angiotensin system in the control of blood
pressure in normal, sodium-replete subjects is not clear. The use of a specific inhibitor of …

Abstract Insertion/deletion (I/D) polymorphism of the angiotensin converting enzyme (ACE)
gene has been shown to be a determinant for serum ACE level and a marker for several …

Angiotensin converting enzyme (ACE) inhibitors induce haemodynamic, humoral and
metabolic actions which have been well characterized during the last decade. The precise …

Background Angiotensin-converting enzyme 2 (ACE2) is a novel regulator of the renin–
angiotensin system that counteracts the adverse effects of angiotensin II. In heart failure …

In a random sample of normotensive and hypertensive fifty-year-old men plasma-renin-
activity (PRA), plasma-renin-concentration (PRC), and renin substrate were measured using …

Angiotensin‐converting enzyme 2 (ACE2) is thought to act in an opposing manner to its
homologue, angiotensin‐converting enzyme (ACE), by inactivating the vasoconstrictor …

Immunohistochemical studies and experiments with microdissected nephron segments
indicate that the angiotensin I converting enzyme (ACE) in the kidney is expressed in the …

1. The levels of plasma renin activity or concentration and plasma angiotensin were similar
in normotensive subjects and in untreated or treated essential hypertensives. 2. There was a …

There is uncertainty about the contribution of angiotensin-converting enzyme (ACE) to
angiotensin II formation, with recent studies suggesting that non-ACE enzymes may be the …